Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Goeree

Showing results (31-40 of 185) with videos related to

Pageof 19
Sort By:
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|February 26, 2015
Harmonization of HTA--based reimbursement and regulatory approval activities: a qualitative studyBernice Tsoi, Daria O'Reilly, Lisa Masucci, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 2, 2002
Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux diseaseAndrew H Briggs, Ron Goeree, Gord Blackhouse, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|November 15, 2007
A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major traumaLarry D Lynd, Ron Goeree, Mark A Crowther, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 15, 2014
Methodological guidance documents for evaluation of ethical considerations in health technology assessment: a systematic reviewNazila Assasi, Lisa Schwartz, Jean-Eric Tarride, et al.
International Journal of Technology Assessment in Health Care|January 26, 2008
Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in ChineseFeng Xie, Nan Luo, Gord Blackhouse, et al.
BMC Health Services Research|January 23, 2015
Economic burden of illness associated with diabetic foot ulcers in CanadaRobert B Hopkins, Natasha Burke, John Harlock, et al.
Genetic Testing and Molecular Biomarkers|September 27, 2012
Economic evaluations conducted for assessment of genetic testing technologies: a systematic reviewNazila Assasi, Lisa Schwartz, Jean-Eric Tarride, et al.
Hospital Practice (1995)|May 23, 2012
Patient management, and time and health care resource utilization associated with the use of intravenous bisphosphonates for patients with metastatic bone disease: a Delphi studyFeng Xie, Rob Hopkins, Natasha Burke, et al.
International Journal of Technology Assessment in Health Care|July 17, 2015
Barriers and facilitators influencing ethical evaluation in health technology assessmentNazila Assasi, Lisa Schwartz, Jean-Eric Tarride, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 19, 2003
Oseltamivir for treatment of influenza in healthy adults: pooled trial evidence and cost-effectiveness model for CanadaBernie J O'Brien, Ron Goeree, Gordon Blackhouse, et al.
Pageof 19

Showing results (31-40 of 185) with videos related to

Sort By:
Pageof 19
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|February 26, 2015
Harmonization of HTA--based reimbursement and regulatory approval activities: a qualitative studyBernice Tsoi, Daria O'Reilly, Lisa Masucci, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 2, 2002
Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux diseaseAndrew H Briggs, Ron Goeree, Gord Blackhouse, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|November 15, 2007
A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major traumaLarry D Lynd, Ron Goeree, Mark A Crowther, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 15, 2014
Methodological guidance documents for evaluation of ethical considerations in health technology assessment: a systematic reviewNazila Assasi, Lisa Schwartz, Jean-Eric Tarride, et al.
International Journal of Technology Assessment in Health Care|January 26, 2008
Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in ChineseFeng Xie, Nan Luo, Gord Blackhouse, et al.
BMC Health Services Research|January 23, 2015
Economic burden of illness associated with diabetic foot ulcers in CanadaRobert B Hopkins, Natasha Burke, John Harlock, et al.
Genetic Testing and Molecular Biomarkers|September 27, 2012
Economic evaluations conducted for assessment of genetic testing technologies: a systematic reviewNazila Assasi, Lisa Schwartz, Jean-Eric Tarride, et al.
Hospital Practice (1995)|May 23, 2012
Patient management, and time and health care resource utilization associated with the use of intravenous bisphosphonates for patients with metastatic bone disease: a Delphi studyFeng Xie, Rob Hopkins, Natasha Burke, et al.
International Journal of Technology Assessment in Health Care|July 17, 2015
Barriers and facilitators influencing ethical evaluation in health technology assessmentNazila Assasi, Lisa Schwartz, Jean-Eric Tarride, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 19, 2003
Oseltamivir for treatment of influenza in healthy adults: pooled trial evidence and cost-effectiveness model for CanadaBernie J O'Brien, Ron Goeree, Gordon Blackhouse, et al.
Pageof 19